News

The UK community will benefit thanks to a £5.64M investment from UK research funders.

Acquisition significantly expands contract manufacturing capabilities to include commercial scale sterile injectables.

The latest in collaborative analytical capability now available on-demand to Government and Healthcare Organisations enabling data-driven healthcare.

The device will mean that appropriate measures could be taken more quickly to limit the spread of the infectious disease.

New study from Wyatt Technology showcases developments in the ability to characterize colloidal stability to establish suitability of protein formulations for drug therapeutics.

Study represents the first time this critical step has been demonstrated in a laboratory.

Funding will be used to launch new stem cell products for drug discovery and regenerative medicine.

Company has filed articles of amalgamation to merge with Trillium Therapeutics.

The acquisition strengthens Provence Technologies’ expertise in its core business of therapeutic chemistry.

Sleeping well is a crucial factor contributing to our physical and mental restoration. SWS in particular has a positive impact for instance on memory and the functioning of the immune system. During periods of SWS, growth hormones are secreted, cell repair is promoted and the defense system is stimulated.